CrowdOptic's management team are specialists in contextual technology innovation. They include former members of the identity management team at Oracle, acquired through Oracle's acquisition of Bharosa in 2007. The CrowdOptic team includes co-inventors of five patents now held by Oracle, including the contextual authentication capability of Oracle's Adaptive Access Manager product. CrowdOptic's US patent application for focal context in mobile received a notice of patent allowance on July 12, 2013.About CrowdOpticCrowdOptic uses real-time sensor data from electronic devices and its own patent-allowed CrowdOptic algorithms to identify and track where devices are aimed (focus) and to identify groups of people with the same focus. CrowdOptic can instantly filter mobile media and create new opportunities for eyewitness engagement. It is used around the world to power a wide range of apps that let users aim their phones to connect, report news, find friends, alternate broadcasts, cast a vote and discover others who share their focus and interests. CrowdOptic technology, which includes sensor data smoothing, EXIF data mining and focal analytics, is instantly deployable in a range of mobile applications and technology environments to enhance broadcasting, security, social media sharing and advertising. CrowdOptic is a privately-held, venture-backed company based in San Francisco. www.crowdoptic.com.
CrowdOptic Announces US Patent Allowance For Capabilities Essential To Mobile And Wearable Apps; Company Opens APIs For Apps Developers
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.